Syner-G

SEPTEMBER 15, 2023

Nonetheless, their rising popularity – eight of the top 10 best-selling drugs internationally in 2016 were biologics – underscores their increasing importance. 5 Key Steps in Large Molecule (Biologics) Development Target Identification Drug discovery involves identifying biological targets relevant to diseases.

Drug Development 59

Drug Development Documentation Process Improvement Compounding 59

pharmaphorum

JANUARY 29, 2021

They wanted someone who had lots of experience in drug development, was a molecular biologist, and was stubborn enough to take on CRISPR!” When I started in 2016 it was still a very academic field without much industrial interest. billion in funding. It’s just a matter of getting the field there.”. About the interviewee.

Documentation 145

Documentation Drug Development 145

pharmaphorum

APRIL 27, 2021

Briefing documents published by the FDA ahead of the meeting suggest that discussion will focus on ongoing trials that may serve as alternative confirmatory studies. In 2016, the agency was criticised by the US Government Accountability Office (GAO) for not gathering enough post-marketing data on drugs granted expedited approvals.

Chemotherapy 90

Chemotherapy Documentation Drug Development 90

European Pharmaceutical Review

JULY 4, 2024

The second was crofelemer, Mytesi , an indicator drug for HIV-associated diarrhoea extracted from the blood-red latex of the South American croton tree. 2 It was first approved as Fulyzaq in December 2012 and in October 2016, Napo Pharmaceuticals launched the new brand, Mytesi. 3 Is two too few? BMB Reports. 2017;50(3):111–6.

Drug Development 103

Drug Development Biosimilars Documentation Labelling 103

pharmaphorum

OCTOBER 29, 2020

Figure 2: NICE OMA safe harbour meetings, 2016/17 to 2019/20. For PRIMA, the agency quotes Peter Wheatley-Price, market access and pricing director at Takeda UK, who said : “The Takeda team highly regarded the quality of the PRIMA reports and model review documentation. Source: Data from NICE FOI responses. Great job!”.

Documentation 101

Documentation Drug Development 101

Putting Patients First Blog

APRIL 30, 2024

Key Points of Support Conciseness and Focus of Key Information The NHC supports the FDA’s emphasis on beginning the informed consent document with concise, focused presentations of key information. The importance of using plain language in health communications is well-documented in literature.

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

Putting Patients First Blog

FEBRUARY 6, 2024

The price of progress: funding and financing Alzheimer’s disease drug development. Progress in rare diseases research 2010-2016: an IRDiRC perspective. autm.net/AUTMMain/media/Partner-Events/Documents/Economic-_Contribution_University- Nonprofit_Inventions_US_1996-2015_BIO_AUTM.pdf 16 Lanahan, L., link] 3 Cummings, J.,

Communication 40

Communication Documentation Drug Development 40